NCT01622140View on ClinicalTrials.gov

Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis

CompletedOBSERVATIONAL
Enrollment

21,334

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Latent Tuberculosis InfectionTuberculosis
Trial Locations (10)

21201

Maryland Department of Public Health, Baltimore

27708

Duke University, Durham

30303

Emory University, Atlanta

32611

University of Florida Board of Trustees, Gainesville

76107

University of North Texas Health Science Center, Fort Worth

80204

Denver Health and Hospitals Authority, Denver

85006

Maricopa County Department of Public Health, Phoenix

94804

California Department of Public Health, Richmond

96817

Hawaii Department of Health, Honolulu

98104

Public Health Seattle-King County, Seattle

All Listed Sponsors
lead

Centers for Disease Control and Prevention

FED

NCT01622140 - Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis | Biotech Hunter | Biotech Hunter